Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients

Prog Clin Biol Res. 1990:348:137-50.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / surgery
  • Carcinoma, Renal Cell / therapy*
  • Combined Modality Therapy
  • Drug Evaluation
  • Female
  • France / epidemiology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interferon Type I / administration & dosage
  • Interferon Type I / therapeutic use*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / surgery
  • Kidney Neoplasms / therapy*
  • Male
  • Middle Aged
  • Nephrectomy
  • Recombinant Proteins
  • Remission Induction
  • Survival Rate
  • Vinblastine / therapeutic use*

Substances

  • Immunologic Factors
  • Interferon Type I
  • Recombinant Proteins
  • Vinblastine